Company Filing History:
1 out of 25 
1 out of 64 Years Active: 2023
Title: Maureen Deehan: Innovator in Antibody-Drug Conjugates
Introduction
Maureen Deehan is a notable inventor based in Zug, Switzerland. She has made significant contributions to the field of biotechnology, particularly in the development of antibody-drug conjugates. Her work focuses on innovative therapeutic solutions that target specific antigens, enhancing the efficacy of treatments.
Latest Patents
Maureen Deehan holds 1 patent for her invention titled "Compositions and methods related to anti-CD19 antibody drug conjugates." This patent describes antibody-drug conjugates (ADCs) where one or more active agents are linked to an anti-CD19 antibody through a specialized linker. The invention includes monoclonal antibodies and various forms that specifically bind to CD19, along with methods for their therapeutic, diagnostic, and prophylactic applications.
Career Highlights
Throughout her career, Maureen has worked with prominent companies in the biotechnology sector. Notable among these are Legochem Biosciences, Inc. and Novimmune SA. Her experience in these organizations has allowed her to refine her expertise in antibody development and drug conjugation techniques.
Collaborations
Maureen has collaborated with esteemed colleagues, including Ho Young Song and Yun Hee Park. These partnerships have contributed to her innovative research and the advancement of her patented technologies.
Conclusion
Maureen Deehan's work in the field of antibody-drug conjugates represents a significant advancement in targeted therapies. Her contributions continue to influence the development of innovative treatments for various medical conditions.